AI-driven nano-repair: the future of skin barrier restoration in atopic dermatitis.
作者信息
Talha Muhammad, Khalid Maliha, Shamim Laiba, Waafira Aminath
机构信息
Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
出版信息
Ann Med Surg (Lond). 2025 Jun 23;87(8):5342-5343. doi: 10.1097/MS9.0000000000003517. eCollection 2025 Aug.
Abstract
摘要
相似文献
1
AI-driven nano-repair: the future of skin barrier restoration in atopic dermatitis.人工智能驱动的纳米修复：特应性皮炎皮肤屏障修复的未来。
Ann Med Surg (Lond). 2025 Jun 23;87(8):5342-5343. doi: 10.1097/MS9.0000000000003517. eCollection 2025 Aug.
2
Restoration of Skin Barrier Abnormalities with IL4/13 Inhibitors and Jak Inhibitors in Atopic Dermatitis: A Systematic Review.特应性皮炎中使用 IL4/13 抑制剂和 Jak 抑制剂修复皮肤屏障异常：系统评价。
Medicina (Kaunas). 2024 Aug 22;60(8):1376. doi: 10.3390/medicina60081376.
3
Difamilast topically ameliorates pruritus, dermatitis, and barrier dysfunction in atopic dermatitis model mice by inhibiting phosphodiesterase 4, especially the 4B subtype.双法米司特通过抑制磷酸二酯酶4（尤其是4B亚型）局部改善特应性皮炎模型小鼠的瘙痒、皮炎和屏障功能障碍。
J Pharmacol Exp Ther. 2025 Jun;392(6):103582. doi: 10.1016/j.jpet.2025.103582. Epub 2025 Apr 14.
4
Changes in skin barrier integrity by electrical impedance spectroscopy during dupilumab treatment on a child with severe atopic dermatitis.电阻抗光谱法评估度普利尤单抗治疗儿童重症特应性皮炎时皮肤屏障完整性的变化。
Turk J Pediatr. 2024 Nov 16;66(5):637-642. doi: 10.24953/turkjpediatr.2024.4902.
5
Natural Turmeric-Derived Nanovesicles-Laden Metal-Polyphenol Hydrogel Synergistically Restores Skin Barrier in Atopic Dermatitis via a Dual-Repair Strategy.
Adv Healthc Mater. 2025 Aug;14(20):e2500081. doi: 10.1002/adhm.202500081. Epub 2025 Apr 29.
6
Unlocking the potential of lipidomic analysis in canine atopic dermatitis research: Insights from a pilot study.挖掘脂质组学分析在犬特应性皮炎研究中的潜力：一项初步研究的见解
Vet Dermatol. 2025 Aug;36(4):462-473. doi: 10.1111/vde.13363. Epub 2025 Jun 12.
7
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.阿布昔替尼、特利鲁单抗和乌帕替尼治疗中重度特应性皮炎。
Health Technol Assess. 2024 Jan;28(4):1-113. doi: 10.3310/LEXB9006.
8
Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review.特应性皮炎中的细胞因子和表皮脂质异常：系统评价。
Cells. 2023 Dec 8;12(24):2793. doi: 10.3390/cells12242793.
9
Unique dermal bacterial signature differentiates atopic dermatitis skin from healthy.独特的皮肤细菌特征可区分特应性皮炎皮肤与健康皮肤。
mSphere. 2025 Jun 25;10(6):e0015625. doi: 10.1128/msphere.00156-25. Epub 2025 May 9.
10
Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16.在第16周时皮肤未达到清除或几乎清除状态的中度至重度特应性皮炎青少年患者中，使用曲罗替尼单抗治疗后的临床意义改善情况。
Dermatol Ther (Heidelb). 2025 Jul 28. doi: 10.1007/s13555-025-01484-1.
本文引用的文献
1
Construction and Evaluation of an Artificial Intelligence Assistant Decision-Making System Focused on the Treat-to-Target Framework and Full Process Management for Atopic Dermatitis: Study Protocol for a Randomized Controlled Trial.聚焦特应性皮炎达标治疗框架及全程管理的人工智能辅助决策系统的构建与评估：一项随机对照试验的研究方案
J Clin Med. 2025 Apr 27;14(9):3015. doi: 10.3390/jcm14093015.
2
Reductive Adjuvant Nanosystem for Alleviated Atopic Dermatitis Syndromes.
ACS Nano. 2025 Feb 4;19(4):4195-4212. doi: 10.1021/acsnano.4c08767. Epub 2025 Jan 23.
3
Development and application of novel peptide-formulated nanoparticles for treatment of atopic dermatitis.新型肽配方纳米颗粒治疗特应性皮炎的开发与应用。
J Mater Chem B. 2023 Nov 1;11(42):10131-10146. doi: 10.1039/d3tb01202f.
Zotero 插件